Previous close | 35.32 |
Open | 35.30 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 34.95 - 35.42 |
52-week range | 31.02 - 50.10 |
Volume | |
Avg. volume | 2,981 |
Market cap | N/A |
Beta (5Y monthly) | 0.64 |
PE ratio (TTM) | 0.17 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.
Baxter International Inc. ( NYSE:BAX ) will pay a dividend of $0.29 on the 1st of July. This means the annual payment...
Baxter International ( NYSE:BAX ) First Quarter 2024 Results Key Financial Results Revenue: US$3.59b (up 2.2% from 1Q...